Publicaciones (146) Publicaciones de MARÍA MAGDALENA SALCEDO PLAZA

2024

  1. Demographic Trends in Liver Transplant Survivors after 3 Decades of Program Implementation: The Impact of Cohort and Period Effects on Life Expectancy

    Transplantation Direct, Vol. 10, Núm. 8, pp. e1684

  2. Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors

    Journal of Hepatology, Vol. 80, Núm. 6, pp. 904-912

  3. Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study

    Annals of Hepatology, Vol. 29, Núm. 3

  4. Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry

    Liver International, Vol. 44, Núm. 9, pp. 2303-2314

  5. The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis

    Liver International, Vol. 44, Núm. 2, pp. 279-285

  6. Unusual early post-transplant hepatic dysfunction

    Journal of Hepatology, Vol. 80, Núm. 1, pp. e11-e13

  7. Why your doctor is not an algorithm: Exploring logical principles of different clinical inference methods using liver transplantation as a model

    Gastroenterologia y Hepatologia

2023

  1. Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration

    Hepatology, Vol. 77, Núm. 4, pp. 1095-1105

  2. CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma

    JHEP Reports, Vol. 5, Núm. 3

  3. Implementation and impact of an antibiotic control program and multidrug-resistant bacterial colonization in a liver transplant unit

    Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 7, pp. 357-361

  4. Liver Transplantation for Fulminant Hepatic Failure in a Young Woman

    American Journal of Transplantation

  5. Long term SARS-CoV-2-specific cellular immunity after COVID-19 in liver transplant recipients

    Journal of Microbiology, Immunology and Infection, Vol. 56, Núm. 3, pp. 526-536

  6. Posterior reversible encephalopathy syndrome (PRES) in post-liver transplantation

    Revista Espanola de Enfermedades Digestivas

  7. Resilience After COVID-19: A Descriptive, Cross-Sectional Study

    Clinical Nursing Research, Vol. 32, Núm. 3, pp. 618-628

  8. Tolvaptan in portal hypertension: real life experience

    Revista espanola de enfermedades digestivas, Vol. 115, Núm. 4, pp. 206

2022

  1. Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation

    American Journal of Transplantation, Vol. 22, Núm. 6, pp. 1671-1682

  2. Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019

    Liver Transplantation, Vol. 28, Núm. 6, pp. 1039-1050

  3. Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study

    Alimentary Pharmacology and Therapeutics, Vol. 56, Núm. 1, pp. 131-143

  4. Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 6, pp. 335-342

  5. Evaluation and Management of Liver Transplant Candidates with Prior Nonhepatic Cancer: Guidelines from the ILTS/SETH Consensus Conference

    Transplantation